NDC codes

FDA NDC Directory
Product NDC (as listed)87069-121Labeler and product segments. Claims need a package NDC.
Product NDC at billing width87069-0121Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
87069-121-63870690121638 POUCH in 1 CARTON (87069-121-63) / 3 BAG in 1 POUCH / 70 mL in 1 BAGMarketed from Jun 23, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Blood Collection System
Generic name (nonproprietary)
cp2d/as-3 triple with sampling system
Active ingredients
Dextrose, Unspecified form — 3.57 g/70mL
Dosage form
Solution
Route
Intravenous
Labeler
GVS TM INCNDC labeler code 87069
Product type
Prescription drug
Marketing category
NDA — New Drug ApplicationApplication BN 820915
Marketing start
Listing expires
Identifiers
Product ID 87069-121_54e8cfd2-f91c-8381-e063-6394a90a3f77SPL ID 54e8cfd2-f91c-8381-e063-6394a90a3f77SPL set ID 54e8cfd2-f91b-8381-e063-6394a90a3f77UNII IY9XDZ35W2

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N487069012163 followed by a unit qualifier and the quantity

Package 87069-0121-63. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Full label on DailyMed (opens in a new tab)

About NDC 87069-121

What is NDC 87069-121?
87069-121 is the product NDC for Blood Collection System (cp2d/as-3 triple with sampling system), Dextrose, Unspecified form 3.57 g/70mL solution, listed with the FDA by GVS TM INC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Blood Collection System (CP2D/AS-3 triple with sampling system).
What is the active ingredient?
Dextrose, Unspecified form.
Who is the labeler?
GVS TM INC, NDC labeler code 87069. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Blood Collection System?
None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other NDCs under BN 820915

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BN 820915
ProductStrengthForm · routeLabelerProduct NDC
Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-123
Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-126
Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-123
Leukotrap RC PL Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-123
Leukotrap WB System - CP2Dcp2d/as-3 - anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-126
Leukotrap RC Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-129
Leukotrap RC Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-129
Leukotrap RC Systemcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.57 g/70mLSolutionIntravenousGVS TM INC87069-129
Cp2DDextrose, Unspecified form 4.64 g/100mLSolutionIntravenousGVS TM INC87069-455
Leukotrap WB system - CP2Dcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.21 g/63mLSolutionIntravenousGVS TM INC87069-726
As-3Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mLSolutionIntravenousGVS TM INC87069-460
As-3Adenine .03 g/100mL; Dextrose, Unspecified form 1 g/100mLSolutionIntravenousGVS TM INC87069-462
Leukotrap WB system - CP2Dcp2d/as-3 anticoagulant and additive systemDextrose, Unspecified form 3.21 g/63mLSolutionIntravenousGVS TM INC87069-726

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in